Chia seeds deserve special mention for GLP-1 users
If side effects are affecting your experience or raising questions about next steps, a short assessment can help provide clarity
Ozempic and Vision Risks: What You Need to Know The diabetes drug semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, has proven effective in controlling blood sugar and aiding weight loss
Often there are interactions among these factors that compound AD/ADRD risk
Start your intake How Ashwagandha and GLP-1 Medications Work Differently Ashwagandha is an adaptogenic herb that influences cortisol levels and stress-response pathways in your nervous system
Hanmi Pharmaceutical begins phase 3 clinical trials in Korea, outpacing competitors in development speed Most new drugs are GLP-1-based, Yuhan Corporation set sights on GDF-15 In 2022, the domestic obesity market reached KRW 175.7 billion [by Eum, Sang Jun] Major Korean pharmaceutical companies are in a competitive race to develop obesity treatments, as they are rapidly gaining popularity
